Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Antivirals Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Nucleoside Analogs
1.2.3 Neuraminidase Inhibitors
1.2.4 Ion Channel Blockers
1.2.5 Fusion Protein Inhibitors
1.3 Market by Application
1.3.1 Global Respiratory Antivirals Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Upper Respiratory Tract Infections (URTIs)
1.3.3 Influenza
1.3.4 Bronchiolitis
1.3.5 Pneumonia
1.3.6 Measles
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Antivirals Market Perspective (2018-2033)
2.2 Respiratory Antivirals Growth Trends by Region
2.2.1 Global Respiratory Antivirals Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Respiratory Antivirals Historic Market Size by Region (2018-2023)
2.2.3 Respiratory Antivirals Forecasted Market Size by Region (2024-2033)
2.3 Respiratory Antivirals Market Dynamics
2.3.1 Respiratory Antivirals Industry Trends
2.3.2 Respiratory Antivirals Market Drivers
2.3.3 Respiratory Antivirals Market Challenges
2.3.4 Respiratory Antivirals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Antivirals Players by Revenue
3.1.1 Global Top Respiratory Antivirals Players by Revenue (2018-2023)
3.1.2 Global Respiratory Antivirals Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Antivirals Revenue
3.4 Global Respiratory Antivirals Market Concentration Ratio
3.4.1 Global Respiratory Antivirals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Antivirals Revenue in 2022
3.5 Respiratory Antivirals Key Players Head office and Area Served
3.6 Key Players Respiratory Antivirals Product Solution and Service
3.7 Date of Enter into Respiratory Antivirals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Antivirals Breakdown Data by Type
4.1 Global Respiratory Antivirals Historic Market Size by Type (2018-2023)
4.2 Global Respiratory Antivirals Forecasted Market Size by Type (2024-2033)
5 Respiratory Antivirals Breakdown Data by Application
5.1 Global Respiratory Antivirals Historic Market Size by Application (2018-2023)
5.2 Global Respiratory Antivirals Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Respiratory Antivirals Market Size (2018-2033)
6.2 North America Respiratory Antivirals Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Respiratory Antivirals Market Size by Country (2018-2023)
6.4 North America Respiratory Antivirals Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Respiratory Antivirals Market Size (2018-2033)
7.2 Europe Respiratory Antivirals Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Respiratory Antivirals Market Size by Country (2018-2023)
7.4 Europe Respiratory Antivirals Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Antivirals Market Size (2018-2033)
8.2 Asia-Pacific Respiratory Antivirals Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Respiratory Antivirals Market Size by Region (2018-2023)
8.4 Asia-Pacific Respiratory Antivirals Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Respiratory Antivirals Market Size (2018-2033)
9.2 Latin America Respiratory Antivirals Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Respiratory Antivirals Market Size by Country (2018-2023)
9.4 Latin America Respiratory Antivirals Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Antivirals Market Size (2018-2033)
10.2 Middle East & Africa Respiratory Antivirals Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Respiratory Antivirals Market Size by Country (2018-2023)
10.4 Middle East & Africa Respiratory Antivirals Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Respiratory Antivirals Introduction
11.1.4 GSK Revenue in Respiratory Antivirals Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Respiratory Antivirals Introduction
11.2.4 Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Respiratory Antivirals Introduction
11.3.4 AstraZeneca Revenue in Respiratory Antivirals Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Respiratory Antivirals Introduction
11.4.4 Merck Revenue in Respiratory Antivirals Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Respiratory Antivirals Introduction
11.5.4 Novartis Revenue in Respiratory Antivirals Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Beximco Pharmaceuticals
11.6.1 Beximco Pharmaceuticals Company Detail
11.6.2 Beximco Pharmaceuticals Business Overview
11.6.3 Beximco Pharmaceuticals Respiratory Antivirals Introduction
11.6.4 Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2018-2023)
11.6.5 Beximco Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Respiratory Antivirals Introduction
11.7.4 Pfizer Revenue in Respiratory Antivirals Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche Respiratory Antivirals Introduction
11.8.4 Roche Revenue in Respiratory Antivirals Business (2018-2023)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Detail
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Respiratory Antivirals Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2018-2023)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Respiratory Antivirals Introduction
11.10.4 Johnson & Johnson Revenue in Respiratory Antivirals Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 AbbVie Inc.
11.11.1 AbbVie Inc. Company Detail
11.11.2 AbbVie Inc. Business Overview
11.11.3 AbbVie Inc. Respiratory Antivirals Introduction
11.11.4 AbbVie Inc. Revenue in Respiratory Antivirals Business (2018-2023)
11.11.5 AbbVie Inc. Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Detail
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Respiratory Antivirals Introduction
11.12.4 Sanofi Revenue in Respiratory Antivirals Business (2018-2023)
11.12.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Respiratory Antivirals Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Nucleoside Analogs
Table 3. Key Players of Neuraminidase Inhibitors
Table 4. Key Players of Ion Channel Blockers
Table 5. Key Players of Fusion Protein Inhibitors
Table 6. Global Respiratory Antivirals Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Respiratory Antivirals Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Respiratory Antivirals Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Respiratory Antivirals Market Share by Region (2018-2023)
Table 10. Global Respiratory Antivirals Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Respiratory Antivirals Market Share by Region (2024-2033)
Table 12. Respiratory Antivirals Market Trends
Table 13. Respiratory Antivirals Market Drivers
Table 14. Respiratory Antivirals Market Challenges
Table 15. Respiratory Antivirals Market Restraints
Table 16. Global Respiratory Antivirals Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Respiratory Antivirals Market Share by Players (2018-2023)
Table 18. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Antivirals as of 2022)
Table 19. Ranking of Global Top Respiratory Antivirals Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Respiratory Antivirals Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Respiratory Antivirals Product Solution and Service
Table 23. Date of Enter into Respiratory Antivirals Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Respiratory Antivirals Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Respiratory Antivirals Revenue Market Share by Type (2018-2023)
Table 27. Global Respiratory Antivirals Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Respiratory Antivirals Revenue Market Share by Type (2024-2033)
Table 29. Global Respiratory Antivirals Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Respiratory Antivirals Revenue Market Share by Application (2018-2023)
Table 31. Global Respiratory Antivirals Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Respiratory Antivirals Revenue Market Share by Application (2024-2033)
Table 33. North America Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Respiratory Antivirals Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Respiratory Antivirals Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Respiratory Antivirals Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Respiratory Antivirals Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Respiratory Antivirals Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Respiratory Antivirals Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Respiratory Antivirals Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Respiratory Antivirals Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Respiratory Antivirals Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Respiratory Antivirals Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Respiratory Antivirals Market Size by Country (2024-2033) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Respiratory Antivirals Product
Table 51. GSK Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Boehringer Ingelheim Company Detail
Table 54. Boehringer Ingelheim Business Overview
Table 55. Boehringer Ingelheim Respiratory Antivirals Product
Table 56. Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 57. Boehringer Ingelheim Recent Development
Table 58. AstraZeneca Company Detail
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Respiratory Antivirals Product
Table 61. AstraZeneca Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 62. AstraZeneca Recent Development
Table 63. Merck Company Detail
Table 64. Merck Business Overview
Table 65. Merck Respiratory Antivirals Product
Table 66. Merck Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Novartis Company Detail
Table 69. Novartis Business Overview
Table 70. Novartis Respiratory Antivirals Product
Table 71. Novartis Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Beximco Pharmaceuticals Company Detail
Table 74. Beximco Pharmaceuticals Business Overview
Table 75. Beximco Pharmaceuticals Respiratory Antivirals Product
Table 76. Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 77. Beximco Pharmaceuticals Recent Development
Table 78. Pfizer Company Detail
Table 79. Pfizer Business Overview
Table 80. Pfizer Respiratory Antivirals Product
Table 81. Pfizer Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 82. Pfizer Recent Development
Table 83. Roche Company Detail
Table 84. Roche Business Overview
Table 85. Roche Respiratory Antivirals Product
Table 86. Roche Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 87. Roche Recent Development
Table 88. Bristol-Myers Squibb Company Company Detail
Table 89. Bristol-Myers Squibb Company Business Overview
Table 90. Bristol-Myers Squibb Company Respiratory Antivirals Product
Table 91. Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 92. Bristol-Myers Squibb Company Recent Development
Table 93. Johnson & Johnson Company Detail
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Respiratory Antivirals Product
Table 96. Johnson & Johnson Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 97. Johnson & Johnson Recent Development
Table 98. AbbVie Inc. Company Detail
Table 99. AbbVie Inc. Business Overview
Table 100. AbbVie Inc. Respiratory Antivirals Product
Table 101. AbbVie Inc. Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 102. AbbVie Inc. Recent Development
Table 103. Sanofi Company Detail
Table 104. Sanofi Business Overview
Table 105. Sanofi Respiratory Antivirals Product
Table 106. Sanofi Revenue in Respiratory Antivirals Business (2018-2023) & (US$ Million)
Table 107. Sanofi Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Antivirals Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Respiratory Antivirals Market Share by Type: 2022 VS 2033
Figure 3. Nucleoside Analogs Features
Figure 4. Neuraminidase Inhibitors Features
Figure 5. Ion Channel Blockers Features
Figure 6. Fusion Protein Inhibitors Features
Figure 7. Global Respiratory Antivirals Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Respiratory Antivirals Market Share by Application: 2022 VS 2033
Figure 9. Upper Respiratory Tract Infections (URTIs) Case Studies
Figure 10. Influenza Case Studies
Figure 11. Bronchiolitis Case Studies
Figure 12. Pneumonia Case Studies
Figure 13. Measles Case Studies
Figure 14. Others Case Studies
Figure 15. Respiratory Antivirals Report Years Considered
Figure 16. Global Respiratory Antivirals Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Respiratory Antivirals Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Respiratory Antivirals Market Share by Region: 2022 VS 2033
Figure 19. Global Respiratory Antivirals Market Share by Players in 2022
Figure 20. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Antivirals as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Respiratory Antivirals Revenue in 2022
Figure 22. North America Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Respiratory Antivirals Market Share by Country (2018-2033)
Figure 24. United States Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Respiratory Antivirals Market Share by Country (2018-2033)
Figure 28. Germany Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Respiratory Antivirals Market Share by Region (2018-2033)
Figure 36. China Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Respiratory Antivirals Market Share by Country (2018-2033)
Figure 44. Mexico Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Respiratory Antivirals Market Share by Country (2018-2033)
Figure 48. Turkey Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Respiratory Antivirals Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. GSK Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 55. Beximco Pharmaceuticals Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 57. Roche Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 60. AbbVie Inc. Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Respiratory Antivirals Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed